Skip to main content
AMCP Nexus 2023 Main banner

Legislative and Regulatory Trends

(L6) Does Pre-Approval Information Exchange (PIE) Allow Manufacturers to Present Model-Based Outcome Projections to Payers?

Wednesday, October 18, 2023
4:30 PM – 5:45 PM East Coast USA Time
Location: Sabal
CPE
ACPE UAN:0233-0000-23-065-L04-P | Contact Hours: 1.25 | Activity Type: Knowledge-based
This session will present and discuss different methodological approaches that may enable manufacturers to develop early economic models that test assumptions and identify value drivers in a PIE-compliant manner, and thus overcome current barriers and increase the sharing of health economic information during PIE discussions. In addition, the perspective of the managed care pharmacist on how early health economic models guide decision-making and provide important insights that could be developed following the rules of PIE, how they would be received and utilized, and how they would change the drug review and reimbursement process will also be discussed. Finally, the session will address the need for and value of traditional models that support budget planning. Managed care pharmacists, manufacturers, and other individuals who either develop PIE materials or are involved in PIE communications will gain important insights from this session.

Learning Objectives::

At the completion of this activity, participants should be able to:
  1. Identify key challenges that could limit the ability of manufacturers to share health economic models with managed care pharmacists during PIE discussions.
  2. Describe how new methodological approaches may enable manufacturers to develop PIE-compliant economic models and share health economic information during PIE discussions.
  3. Discuss the perspective of the managed care pharmacist on how early health economic models could be developed following the rules of PIE.
  4. Explain the need for and value of more traditional models to support budget planning in addition to early economic models.